Clinical Trial Update: Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis [Phase 3]

View source ↗

Summary

This document describes a Phase 3 pediatric trial comparing ozanimod to fingolimod in children and adolescents with relapsing-remitting multiple sclerosis, whic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• GILENYA (FINGOLIMOD HCL)
• Zeposia (ozanimod hydrochloride)

Snippet

Sponsor: Celgene | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 3 | Status: RECRUITING